XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jul. 29, 2023
Jul. 30, 2022
Jul. 29, 2023
Jul. 30, 2022
Net sales $ 1,139,361 $ 1,346,221 $ 2,262,938 $ 2,720,935
Cost of sales (exclusive of depreciation expense shown separately below) 763,477 907,673 1,494,585 1,777,793
Gross margin 375,884 438,548 768,353 943,142
Selling and administrative expenses 456,689 510,444 1,073,755 991,223
Depreciation expense 41,282 37,197 77,864 74,553
Operating loss (122,087) (109,093) (383,266) (122,634)
Interest expense (11,175) (3,904) (20,324) (6,654)
Other income (expense) 0 257 5 1,297
Loss before income taxes (133,262) (112,740) (403,585) (127,991)
Income tax expense (benefit) 116,575 (28,590) 52,325 (32,759)
Net loss and comprehensive loss $ (249,837) $ (84,150) $ (455,910) $ (95,232)
Earnings (loss) per common share        
Earnings (loss) per common share - basic (in dollars per share) $ (8.56) $ (2.91) $ (15.67) $ (3.31)
Earnings (loss) per common share - diluted (in dollars per share) $ (8.56) $ (2.91) $ (15.67) $ (3.31)
Weighted-average common shares outstanding:        
Basic 29,175 28,919 29,096 28,770
Dilutive effect of share-based awards 0 0 0 0
Diluted 29,175 28,919 29,096 28,770
Cash dividends declared per common share $ 0 $ 0.30 $ 0.30 $ 0.60